3-Pyridylacetic Acid Hydrochloride | CAS:6419-36-9

We serve 3-Pyridylacetic Acid Hydrochloride CAS:6419-36-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
3-Pyridylacetic Acid Hydrochloride

Chemical Name:3-Pyridylacetic Acid Hydrochloride
CAS.NO:6419-36-9
Synonyms:3-Pyridylacetic Acid Hydrochloride
2-pyridin-3-ylacetic acid,hydrochloride
2-(Pyridin-3-yl)acetic acid hydrochloride
Pyridin-3-ylacetic acid hydrochloride
 
Physical and Chemical Properties:
Boiling Point 301.6ºC at 760 mmHg
Melting Point 161-163 °C(lit.)
Molecular Formula C7H8ClNO2
Molecular Weight 173.597
 
Specification:
Appearance:Off-white crystals
Assay:≥99.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Risedronate sodium



Contact us for information like 3-Pyridylacetic Acid Hydrochloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Pyridin-3-ylacetic acid hydrochloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Pyridin-3-ylacetic acid hydrochloride Use and application,2-pyridin-3-ylacetic acid,hydrochloride technical grade,usp/ep/jp grade.


Related News: It’s the first confirmed Wuhan coronavirus death from outside of mainland China, and brings the total toll to 305.N-Acetyl-L-Methionine manufacturer Established pharmaceutical companies have abandoned the original model of the entire industry chain, stripped R & D and production links through outsourcing, and shifted their focus to product layout and global operations.N-(4-Oxocyclohexyl)acetamide supplier Higher-risk MDS is a disease with significant unmet need, and we are pleased to be able to support healthcare professionals seeking access to rigosertib, ahead of its commercial launch,” said Mark Corbett, EVP, Inceptua Medicines Access.4-Methyl-3-nitrophenol vendor Higher-risk MDS is a disease with significant unmet need, and we are pleased to be able to support healthcare professionals seeking access to rigosertib, ahead of its commercial launch,” said Mark Corbett, EVP, Inceptua Medicines Access.